1101039

Neeraj Agarwal, MD — FEI 3015403344

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Salt Lake City, UT (United States)

Additional Details

Clinical Investigator (CI)